A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
NCT ID: NCT06343727
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
54 participants
INTERVENTIONAL
2025-07-25
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To determine whether the supplementation of egg white protein pudding in a population of individuals with kidney failure on dialysis is feasible.
* To determine whether egg white protein pudding supplementation improves serum albumin similar to other standard nutritional supplements.
* To determine the effects of the egg white protein pudding on frailty measures, dietary intakes and analytes in the blood. Participants will receive either the egg white pudding (experimental) or control (Ensure plus) at the end of their dialysis treatments 3-days per week for 12 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Nutrition in Maintenance Hemodialysis Patients
NCT02917278
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
NCT02360748
High-Protein Food Snack for Dialysis Patients
NCT04134377
Low Protein Renal Formula as Meal Replacement in Predialysis CKD Patients
NCT05330663
Evaluation of Volume Status in Peritoneal Dialysis Patients
NCT00182338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Egg white protein pudding
Participants will receive egg white pudding at the end of their dialysis treatments 3-days per week.
Egg white protein pudding
Will consume one egg white protein pudding at the end of their dialysis treatments 3-days per week for 12 weeks
: Standard dietary supplement
Participants will receive Ensure Plus at the end of their dialysis treatments 3-days per week.
: Ensure Plus
Will consume one Ensure Plus at the end of their dialysis treatments 3-days per week for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Egg white protein pudding
Will consume one egg white protein pudding at the end of their dialysis treatments 3-days per week for 12 weeks
: Ensure Plus
Will consume one Ensure Plus at the end of their dialysis treatments 3-days per week for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female aged ≥18 years with CKD
* On chronic in-center hemodialysis for \> 3 months
* Serum albumin \<35 g/L
* No expected change in dialysis modality or relocation outside of Winnipeg during the intervention period (12 weeks)
Exclusion Criteria
* History of renal transplant
* Serum albumin ≥ 35 g/L
* Bowel diseases
* Cancer
* Pregnancy
* Receiving chemotherapy treatment
* Inability to consume treatment product
* Allergy to study treatment ingredients
* Planning on starting an exercise program during the duration of the trial
* Inability to obtain written informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Manitoba Egg Farmers
UNKNOWN
Seven Oaks Hospital Chronic Disease Innovation Centre
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seven Oaks General Hospital
Winnipeg, Manitoba, Canada
Health Science Centre
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS25870 (H2023:026)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.